halothane has been researched along with y 27632 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, K; Satoh, Y; Sugiyama, A; Takahara, A; Yoneyama, M | 1 |
Gambaryan, S; Roewer, N; Tas, PW | 1 |
2 other study(ies) available for halothane and y 27632
Article | Year |
---|---|
Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model.
Topics: Amides; Anesthetics, Inhalation; Animals; Blood Pressure; Cardiovascular System; Carrier Proteins; Dogs; Enzyme Inhibitors; Female; Halothane; Heart Rate; Intracellular Signaling Peptides and Proteins; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases | 2003 |
Volatile anesthetics affect the morphology of rat glioma C6 cells via RhoA, ERK, and Akt activation.
Topics: Adrenergic beta-Agonists; Amides; Anesthetics, Inhalation; Animals; Cell Line, Tumor; Cell Shape; Culture Media, Serum-Free; Enzyme Activation; Flavonoids; Glioma; Halothane; Isoflurane; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oncogene Protein v-akt; Pyridines; Rats; rhoA GTP-Binding Protein; Signal Transduction | 2007 |